ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 83 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $188,240 | -77.2% | 31,114 | -70.8% | 0.00% | -50.0% |
| Q2 2023 | $827,332 | +234.3% | 106,615 | +145.5% | 0.00% | +100.0% |
| Q1 2023 | $247,494 | -9.8% | 43,420 | -6.8% | 0.00% | 0.0% |
| Q4 2022 | $274,291 | -50.8% | 46,569 | -73.2% | 0.00% | -50.0% |
| Q3 2022 | $557,000 | -47.2% | 174,065 | -26.0% | 0.00% | -33.3% |
| Q2 2022 | $1,054,000 | -38.2% | 235,336 | -26.3% | 0.00% | -40.0% |
| Q1 2022 | $1,705,000 | +214.6% | 319,355 | +942.2% | 0.01% | +400.0% |
| Q2 2021 | $542,000 | – | 30,641 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $2,698,000 | 8.92% |
| Column Group LLC | 3,568,181 | $15,985,000 | 3.40% |
| Euclidean Capital LLC | 747,550 | $3,349,000 | 2.85% |
| Invus Financial Advisors, LLC | 1,007,575 | $4,514,000 | 2.72% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,082,304 | $4,849,000 | 1.49% |
| Monaco Asset Management SAM | 364,741 | $1,634,000 | 0.71% |
| EcoR1 Capital, LLC | 3,418,068 | $15,313,000 | 0.53% |
| DAFNA Capital Management LLC | 415,926 | $1,863,000 | 0.51% |
| Boxer Capital, LLC | 1,054,000 | $4,722,000 | 0.30% |
| Casdin Capital, LLC | 601,515 | $2,695,000 | 0.23% |